Scarica l'app Stockscreener
0.1882
5.07%
-0.0113
Precedente Chiudi:
$0.1994
Aprire:
$0.1855
Volume 24 ore:
6.87M
Relative Volume:
0.16
Capitalizzazione di mercato:
$17.64M
Reddito:
-
Utile/perdita netta:
$-21.91M
Rapporto P/E:
-0.1263
EPS:
-1.49
Flusso di cassa netto:
-
1 W Prestazione:
-29.89%
1M Prestazione:
+42.65%
6M Prestazione:
-89.37%
1 anno Prestazione:
-93.67%
Intervallo 1D:
$0.1854
$0.194
Intervallo di 1 settimana:
$0.1819
$0.2446
Portata 52W:
$0.08
$3.55
Incannex Healthcare Inc Stock (IXHL) Company Profile
Nome
Incannex Healthcare Inc
Settore
Telefono
61 409 840 786
Indirizzo
8 CENTURY CIRCUIT, NORWEST NSW
Confronta IXHL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IXHL
Incannex Healthcare Inc
|
0.1883 | 19.65M | 0 | -21.91M | 0 | -1.49 |
|
HLN
Haleon Plc Adr
|
11.13 | 50.54B | 14.35B | 1.85B | 0 | 0.4023 |
|
ZTS
Zoetis Inc
|
171.34 | 74.02B | 9.29B | 2.52B | 2.28B | 5.57 |
|
RDHL
Redhill Biopharma Ltd Adr
|
1.86 | 4.22M | 35.75M | 11.57M | -26.25M | -3.8069 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.95 | 45.82B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.27 | 20.31B | 16.54B | -1.64B | 749.00M | -1.45 |
Incannex Healthcare Inc Borsa (IXHL) Ultime notizie
Incannex Expands Advisory Board for OSA Program - TipRanks
Incannex Healthcare Inc. Appoints Four Experts to IHL-42X Obstructive Sleep Apnea Clinical Advisory Board - Nasdaq
Harvard and Emory Leaders Join Incannex's Sleep Apnea Program Ahead of Critical Phase 2 Data - Stock Titan
Cannabis Stocks To Add to Your Watchlist – May 29th - Defense World
Incannex advances to phase 3 trial for sleep apnea treatment By Investing.com - Investing.com South Africa
Cannabis Stocks To Consider – May 28th - Defense World
Incannex Healthcare Advances RePOSA Trial to Phase 3 - TipRanks
Incannex advances to phase 3 trial for sleep apnea treatment - Investing.com Australia
Incannex Healthcare Inc. Advances IHL-42X RePOSA Trial to Phase 3 Following FDA Protocol Clearance - The Manila Times
Incannex Healthcare Advances IHL-42X Reposa Trial To Phase 3 Following FDA Protocol Clearance - marketscreener.com
Breakthrough: FDA Green-Lights Phase 3 Trial for Revolutionary Oral Sleep Apnea Treatment - Stock Titan
Incannex cancels remaining Series A Warrants to reduce dilution By Investing.com - Investing.com South Africa
Promising Cannabis Stocks Worth Watching – May 27th - Defense World
Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 3Q 2025 - BioSpace
Incannex Cancels Series A Warrants to Strengthen Capital - TipRanks
Incannex cancels remaining Series A Warrants to reduce dilution - Investing.com
Incannex Healthcare Inc. Enters Agreement to Cancel Remaining Series A Warrants, Eliminating Up to 347.2 Million Shares from Potential Dilution Ahead of IHL-42X Phase 2 Topline Results - The Manila Times
Incannex Cancels 347M Share Warrant Dilution Before Crucial Sleep Apnea Drug Data Release - Stock Titan
Incannex Healthcare Amends ATM Sales Agreement - TipRanks
SEC Form 424B5 filed by Incannex Healthcare Inc. - Quantisnow
Why E2open Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket - Benzinga
Cannabis Stocks To Research – May 25th - Defense World
Cannabis Stocks To Follow NowMay 24th - MarketBeat
Cannabis Stocks To Follow Now – May 24th - Defense World
Best Cannabis Stocks To Follow Now – May 23rd - Defense World
Top Cannabis Stocks To Keep An Eye On – May 22nd - Defense World
Best Cannabis Stocks To Watch TodayMay 18th - MarketBeat
Top Cannabis Stocks To Follow Now – May 20th - Defense World
Cannabis Stocks To Follow Today – May 19th - Defense World
Incannex Healthcare boosts share offering capacity By Investing.com - Investing.com Nigeria
Incannex Cancels Warrants to Strengthen Shareholder Position - TipRanks
Incannex Healthcare boosts share offering capacity - Investing.com
Incannex Healthcare Expands Share Issuance Agreement - TipRanks
Incannex Healthcare Inc. Executes Strategic Cancellation of 50.4% of Series A Warrants, Significantly Reducing Potential Dilution - The Manila Times
Incannex Healthcare Inc. Completes $16.7 Million Capital Raise to Reduce Potential Shareholder Dilution - Nasdaq
Incannex Healthcare Blocks 175M Share Dilution with Strategic $12.5M Warrant Cancellation - Stock Titan
Why Pegasystems Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket - Benzinga
Best Cannabis Stocks To Watch Today – May 18th - Defense World
Incannex Healthcare (IXHL) Spikes Nearly 49% Pre-Market After Strategic Warrant Deal—Is a Turnaround Brewing? - Stocks Telegraph
Cannabis Stocks To Watch Today – May 17th - Defense World
Cannabis Stocks To Consider – May 16th - Defense World
Promising Cannabis Stocks To Follow Now – May 15th - Defense World
Best Pharmaceutical Stocks To Keep An Eye On – May 14th - Defense World
Pre-market Movers: IXHL, KLRS, HCTI, DOCS... - RTTNews
Medical Stocks To Follow Now – May 14th - Defense World
Incannex Announces Potential Reduction of Up to 50.4% of its Series A Warrants - The Manila Times
Cannabis Stocks To Follow Today – May 14th - Defense World
Why Nasdaq, S&P 500 Futures Are Trading Higher FridayApplied Mat (NASDAQ:AMAT), Amazon.com (NASDAQ:AMZN) - Benzinga
Incannex Healthcare Announces Warrant Reduction Strategy - TipRanks
3 Penny Stocks to Watch Now, 5/15/25 - The Globe and Mail
Wall Street Poised To Open Higher After S&P 500's 4-Day Run: 'Sounds Like Powell Is Expecting More Frequent Bouts Of Stagflation,' Cautions Expert - Benzinga
Incannex Healthcare Inc Azioni (IXHL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.28%
2.99%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):